Obesity and female reproductive function

British Medical Bulletin

Volumn 53, Issue 2, 1997, Pages 341-358

  Pettigrew, R ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ESTROGEN; HORMONE; INSULIN;

BODY MASS; BREAST CANCER; CLINICAL FEATURE; DIET; DISEASE ASSOCIATION; ENDOCRINE FUNCTION; ENDOMETRIUM CANCER; FEMALE; FEMALE FERTILITY; FEMALE GENITAL SYSTEM; FETUS DISEASE; HORMONE SUBSTITUTION; HUMAN; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MENOPAUSE; MENSTRUAL CYCLE; OBESITY; OVARY FUNCTION; OVARY POLYCYSTIC DISEASE; PATIENT COUNSELING; PREGNANCY COMPLICATION; PREGNANCY RATE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SPONTANEOUS ABORTION; THROMBOSIS; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 0031005087     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.bmb.a011617     Document Type: Review

References (12)

1. Stein IF, Leventhal ML. Amenorrhoea associated with bilateral polycystic ovaries. Ann J Obstet Gynecol 1935; 29: 181-91
2. Poison DW, Adams J, Wadsworth J, Franks S. Polycystic ovaries - a common finding in normal women. Lancet 1988; i: 870-2
3. Franks S. Polycystic ovary syndrome - a changing perspective. Clin Endocrinol 1989; 31: 87120
4. Adams J, Franks S, Poison DW et al. Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotrophin releasing hormone. Lancet 1985; ii: 1375-8
5. Robinson S, Kiddy D, Gelding S et al. Decreased insulin sensitivity in women with polycystic ovaries is related to menstrual disturbance. Clin Endocrinol 1993: 39; 368-71
6. Singh KB, Mahajan DK, Wortsman J. Effect of obesity on the hormonal characteristics of the polycystic ovary syndrome. / Reprod Med 1990: 39: 805-8
7. Burghen GA, Givens JR, Kitabci AE. Correlation of hyperandrogenism with hyperinsulinaemia in polycystic ovarian disease. / Clin Endocrinol Metab 1980; 50: 113-5
8. Nestler JE, Clore JN, Blackard WG. The central role of obesity (hyperinsulinaemia) in the pathogenesis of the polycystic ovary syndrome. Am] Obstet Gynecol 1989; 161: 1095-7
9. Adashi EY, Resnick CE, Hernandez ER et al. Insulin-like growth factor-1 as an amplifier of follicle stimulating hormone action: studies on mechanisms and sites of action in cultured rat granulosa cells. Endocrinology 1988; 122; 1583-91
10. Cara JF, Fan J, Azzraello J, Rosenfield RL. Insulin like growth factor 1 enhances luteinizing hormone binding to rat ovarian theca-interstsitial cells. / Clin Invest 1990; 86: 560-5
11. Sharp PS, Kiddy DS, Reed MJ, Anyaoku V, Johnstone DG, Franks S. Correlation of plasma insulin and insulin like growth factor-1 with indices of androgen transport and metabolism in women with polycystic ovary syndrome. Clin Endocrinol 1991; 35: 253-7
12. 2 Hamilton-Fairley D, Kiddy D, Anyaoku V, Koistinen R, Seppala M, Franks S. Response of sex hormone binding globulin and insulin-like growth factor binding protein-1 to an oral glucose